Protective effect of equine butyrylcholinesterase in inhalation intoxication of rats with sarin: Determination of blood and brain cholinesterase activities

Inhalation Toxicology

Volumn 16, Issue 8, 2004, Pages 531-536

  Ševelová, Lucie ^a   Bajgar, Jiří ^a   Saxena, Ashima ^b   Doctor, Bhupendra P ^b  

^a DEPARTMENT OF TOXICOLOGY   (Czech Republic)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; BRAIN ENZYME; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; ERYTHROCYTE ENZYME; FLUORIDE; SARIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BASAL GANGLION; CHEMICAL WARFARE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME REACTIVATION; FEMALE; FRONTAL CORTEX; INTOXICATION; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTECTION; RAT;

ADMINISTRATION, INHALATION; ANIMALS; BRAIN; BUTYRYLCHOLINESTERASE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ANTAGONISM; FEMALE; HORSES; INHALATION EXPOSURE; POISONING; RATS; RATS, WISTAR; SARIN;

ANIMALIA; EQUIDAE;

EID: 3142680397     PISSN: 08958378     EISSN: None     Source Type: Journal    
DOI: 10.1080/08958370490442511     Document Type: Article

References (28)

1. Allon, N., Raveh, L., Gilat, E., Cohen, E., Grunwald, J., and Ashani, Y. 1998. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase. Toxicol. Sci. 43:121-128.
2. Ashani, Y., Shapira, S., Levy, D., Wolfe, A. D., Doctor, B. P., and Raveh, L. 1991. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem. Pharmacol. 41:37-41.
3. Benschop, H. P., de Jong, L. P. A., and Langenberg, J. P. 1995. Inhalation toxicokinetics of C(±)P(±)-soman and (±)-sarin in the guinea-pigs. In Enzymes of the cholinesterase family, eds. D. M. Quinn, A. S. Balasubramanian, B. P. Doctor, and P. Taylor, pp. 361-368. New York: Plenum.
4. Brandeis, R., Raveh, L., Grynwald, J. Cohen, E., and Ashani, Y. 1993. Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats. Pharmacol. Biochem. Behav. 46:889-896.
5. Broomfield, C. A., Maxwell, D. M., Solana, R. P., Castro, C. A., Finger, A. V., and Le, D. E. 1991. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J. Pharmacol. Exp. Ther. 259:633-638.
6. Caranto, G. R., Waibel, K. H., Asher, J. M., Larrison, R. W., Brecht, K. M., Schutz, M. B., Raveh, L., Ashani, Y., Wolfe, A. D., and Maxwell, D. M. 1994. Amplification of the effectiveness of acetylcholinesterase for detoxification of organophosphorus compounds by bis-quaternary oximes. Biochem. Pharmacol. 47:347-357.
7. Doctor, B. P., Blick, D. W., Caranto, G., Castro, C. A., Gentry, M. K., Larrison, R., Maxwell, D. M., Murphy, M. R., Schutz, M., and Waibel, K. 1993. Cholinesterases as scavangers for organophosphorus compounds: Protection of primate performance against soman toxicity. Chem. Biol. Interact. 87:285-293.
8. Doctor, B. P., Maxwell, D. M., Ashani, Y., Saxena, A., and Gordon, R. K. 2001. New approaches to Medical protection against chemical warfare nerve agents. In: Chemical warfare agents: Toxicity at low levels, eds. S. M. Somani and J. A. Romano, Jr., pp. 191-214. New York: CRC Press.
9. Ellman, G. L., Courtney, D. K., Andres, V., and Featherstone, R. M. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:88-95.
10. Kassa, J. 2002. The influence of anticholinergic drug and oxime selection on the effectiveness of antidotal treatment against tabun-induced poisoning in mice. Acta Med. (Hradec Králové) 45:75-78.
11. Kassa, J., and Vachek, J. 2002. A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice. Toxicology 177:179-185.
12. Kuća, K., Bielavský, J., Cabal, J., and Bielavská, M. 2003. Synthesis of a potential reactivator of acetylcholinesterase-1-(4- hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)-propane dibromide. Tetrahedron Lett. 44:3123-3125.
13. Marrs, T. C., Maynard, R. L., and Sidell, F. R., eds. 1996. Chemical warfare agents: Toxicology and treatment. New York: John Wiley and Sons.
14. Maxwell, D. M. 1992. The specifity of carboxylesterase protection against the toxicity of organophosphorus compounds. Toxicol. Appl. Pharmacol. 114:306-312.
15. Maxwell, D. M., and Brecht, K. M. 1991. The role of carboxylesterase in species variation of oxime protection against soman. Neurosci. Biobehav. Rev. 15:135-139.
16. Maxwell, D. M., Brecht, K. M., Lenz, D. E., and O'Neill, B. L. 1988. Effect of carboxyleterase inhibition on carbamate protection against soman toxicity. J. Pharmacol. Exp. Ther. 246:986-991.
17. Maxwell, D. M., Castro, C. A., De La Hoz, D. M., Genry, M. K., Gold, M. B., Solana, R. P., Wolfe, A., and Doctor, B. P. 1992. Protection of rhesus monkeys against soman and prevention of performance decrement by pretreatment with acetylcholinesterase. Toxicol. Appl. Pharmacol. 115:44-49.
18. Maxwell, D. M., Brecht, K. M., Doctor, B. P., and Wolfe, A. D. 1993. Comparison of antidote protection against soman by pyridostigmine, HI-6, and acetylcholinesterase. J. Pharmacol. Exp. Ther. 264:1085-1089.
19. Minami, M., Hui, D. M., Wang, Z., Katsumata, M., Inagaki, H., Li, Q., Inuzuka, S., Mashiko, K., Yamamoto, Y., Ootsuka, T., Boulet, C. A., and Clement, J. G. 1998. Biological monitoring of metabolites of sarin and its by-products in human urine samples. J. Toxicol. Sci. 23:250-254.
20. Polhuijs, M., Langenberg, J. P., and Benschop, H. P. 1997. New method for retrospective detection of exposure to organophosphorus anticholinesterases: Application to alleged sarin victims of japanese terrorists. Toxicol. Appl. Pharmacol. 146:156-161.
21. Raveh, L., Segall, Y., Leader, H., Rotschild, N., Levanon, D., Henis, Y., and Ashani, Y. 1992. Protection against tabun toxicity in mice by rophylaxis with an enzyme hydrolyzing organophosphate esters. Biochem. Pharmacol. 44:397-400.
22. Raveh, L., Grunwald, J., Marcus, D., Papier, Y., Cohen, E., and Ashani, Y. 1993. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization. Biochem. Pharmacol. 45:2465-2474.
23. Raveh, L., Grauer, E., Grunwald, J., Cohen, E., and Ashani, Y. 1997. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Toxicol. Appl. Pharmacol. 145:43-53.
24. Ševelová, L., Vachek, J., and Bajgar, J. 2003. Inhalation apparatus for generating sarin and soman vapors. Acta Med. (Hradec Králové) 46:157-161.
25. Shih, T. M., and McDounagh, J. H. 1999. Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol. Biochem. Behav. 64:147-153.
26. Van Helden, H. P. M., Trap, H. C., Oostdijk, J. P., Kuijpers, W. C., Langenberg, J. P., and Benschop, H. P. 2003. Long-term, low-level exposure of guinea pigs and marmosets to sarin vapor in air: Lowest observable effec level. Toxicol. Appl. Pharmacol. 189:170-179.
27. Wolfe, A. D., Rush, R. S., Doctor, B. P., Koplovitz, I., and Jones, D. 1987. Acetylcholinesterase prophylaxis against organophosphate toxicity. Fundam. Appl. Toxicol. 9:266-270.
28. Wolfe, A. D., Blick, D. W., Murphy, M. R., Miller, S. A., Gentry, M. K., Hartgraves, S. L., and Doctor, B. P. 1992. Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity. Toxicol. Appl. Pharmacol. 117:189-193.